Role of CYP2C19 pharmacogenetic polymorphism on response of esomeprazole in the treatment of GERD

被引：0
|
作者：
Halimi, Shafarul
Abu Hassan, Muhammad Radzi
Ismail, Rusli
Kiew, Kuang Kiat
Zainuddin, Zalwani
Mustapha, Mohd Nazri
Mokhtar, Suraya
机构：
[1] Univ Sains Malaysia, George Town, Malaysia
[2] Hosp Univ Sains Malaysia, George Town, Malaysia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
pharmacogenetics; polymorphism; GERD;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [1] The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19
    Yang, Yao
    Lewis, Joshua P.
    Hulot, Jean-Sebastien
    Scott, Stuart A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (10) : 1599 - 1617
  • [2] The CYP2C19 enzyme polymorphism
    Wedlund, PJ
    PHARMACOLOGY, 2000, 61 (03) : 174 - 183
  • [3] Pharmacogenetic Expression of CYP2C19 in a Pediatric Population
    Pierre-Francois, Marie Josette Deborah
    Gagne, Vincent
    Brukner, Ivan
    Krajinovic, Maja
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (09):
  • [4] CYP2C19 Genetic Polymorphism, Rabeprazole and Esomeprazole Have no Effect on the Antiplatelet Action of Clopidogrel
    El-Halabi, Mustapha M.
    Zgheib, Nathalie
    Mansour, Nabil M.
    Malli, Ahmad
    Ghaith, Ola A.
    Mahfouz, Rami
    Alam, Samir
    Sharara, Ala I.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2013, 62 (01) : 41 - 49
  • [5] Induction of testosterone metabolism by esomeprazole in a CYP2C19*2 heterozygote
    Rosenshein, B
    Flockhart, DA
    Ho, H
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2004, 327 (05): : 289 - 293
  • [6] CYP2C19 gene polymorphism in Ningxia
    Zhen Yang
    Yunqian Xie
    Daya Zhang
    Yan Zou
    Ximei Li
    Runxiang Chen
    Xiaodong Zhang
    Shiju Chen
    Feihu Bai
    Pharmacological Reports, 2023, 75 : 705 - 714
  • [7] CYP2C19 gene polymorphism in Ningxia
    Yang, Zhen
    Xie, Yunqian
    Zhang, Daya
    Zou, Yan
    Li, Ximei
    Chen, Runxiang
    Zhang, Xiaodong
    Chen, Shiju
    Bai, Feihu
    PHARMACOLOGICAL REPORTS, 2023, 75 (03) : 705 - 714
  • [8] Optimal dose regimens of esomeprazole for gastric acid suppression with minimal influence of the CYP2C19 polymorphism
    Lou, Horng-Yuan
    Chang, Chun-Chao
    Sheu, Ming-Thau
    Chen, Ying-Chen
    Ho, Hsiu-O
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (01) : 55 - 64
  • [9] A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism
    Hunfeld, N. G.
    Touw, D. J.
    Mathot, R. A.
    Mulder, P. G. H.
    van Schaik, R. H.
    Kuipers, E. J.
    Kooiman, J. C.
    Geus, W. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 31 (01) : 150 - 159
  • [10] Optimal dose regimens of esomeprazole for gastric acid suppression with minimal influence of the CYP2C19 polymorphism
    Horng-Yuan Lou
    Chun-Chao Chang
    Ming-Thau Sheu
    Ying-Chen Chen
    Hsiu-O Ho
    European Journal of Clinical Pharmacology, 2009, 65
12345